Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · Real-Time Price · USD
1.430
-0.030 (-2.05%)
At close: May 19, 2026, 4:00 PM EDT
1.450
+0.020 (1.40%)
After-hours: May 19, 2026, 6:42 PM EDT
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $194.55 million as of May 19, 2026. Its market cap has increased by 123.75% in one year.
Market Cap
194.55M
Enterprise Value
152.73M
1-Year Change
123.75%
Ranking
Category
Stock Price
$1.43
Market Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $363.46M to $194.55M, a decrease of -46.47%. That is a compound annual growth rate of -8.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 199.99M | -2.54% |
| Dec 31, 2025 | 205.20M | 31.26% |
| Dec 31, 2024 | 156.32M | 117.39% |
| Dec 29, 2023 | 71.91M | -57.49% |
| Dec 30, 2022 | 169.15M | -38.80% |
| Dec 31, 2021 | 276.39M | 38.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MediWound | 210.58M |
| Whitehawk Therapeutics | 210.07M |
| Caribou Biosciences | 203.40M |
| Cartesian Therapeutics | 202.44M |
| Fate Therapeutics | 201.65M |
| Keros Therapeutics | 201.09M |
| Arcturus Therapeutics Holdings | 199.81M |
| Humacyte | 199.46M |